- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Squamous Non-small-cell Lung Cancer in United States
Total 4628 results
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Cell>Point LLCVenn Life Sciences; Biomedical Systems; Numoda; Camargo Pharmaceutical ServicesCompletedNon Small Cell Lung CancerUnited States
-
University of UtahRecruitingNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
Muhammad FurqanBiodesix, Inc.TerminatedNon Small Cell Lung CancerUnited States
-
Addario Lung Cancer Medical InstituteWithdrawn
-
Royal Marsden NHS Foundation TrustBristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited Kingdom
-
Duke UniversityRegeneron PharmaceuticalsRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
John L. Villano, MD, PhDActive, not recruitingSquamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States
-
Regeneron PharmaceuticalsSanofiTerminatedNon-small Cell Lung CancerUnited States, Italy, Lithuania
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Power Life Sciences Inc.Not yet recruiting
-
University of Kansas Medical CenterRecruitingNon-small Cell Lung CancerUnited States
-
University of PennsylvaniaTerminatedNon-small Cell Lung Cancer | Starting Pemetrexed Based Therapy | Unresectable CancerUnited States
-
Leo W. Jenkins Cancer CenterTerminatedLung Neoplasms, Non-Small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IV Non-Small Cell Lung CancerUnited States
-
AVAX TechnologiesTerminatedNon-Small Cell Lung Cancer - Completely ResectableUnited States
-
University of Texas Southwestern Medical CenterCompletedNon-small Cell Lung CancerUnited States
-
Cancer Research and Biostatistics Clinical Trials...Novartis Pharmaceuticals; University of Arizona; Providence Cancer Center, Earle...CompletedNon Small Cell Lung CancerUnited States
-
Michael MannSanofiCompletedNon-small Cell Lung CancerUnited States, China
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
Indiana UniversityNational Institute of General Medical Sciences (NIGMS)RecruitingMelanoma | Non Small Cell Lung CancerUnited States
-
Thomas MarronRecruiting
-
Johns Hopkins UniversityAstraZenecaEnrolling by invitationNon-small Cell Lung Cancer (NSCLC)United States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
Fox Chase Cancer CenterTerminatedNon Small Cell Lung Cancer Stage IIIBUnited States
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Megan Daly, MDGenentech, Inc.Active, not recruitingStage I Non-Small Cell Lung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterPeregrine PharmaceuticalsCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
Stanford UniversityEli Lilly and Company; Genentech, Inc.CompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
NYU Langone HealthRecruitingNon-small Cell Lung Cancer With STK11/LKB1 MutationUnited States
-
Indiana UniversityCompletedNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteTerminatedNon Small Cell Lung CancerUnited States
-
University of VirginiaNational Cancer Institute (NCI)Completed
-
CellSight Technologies, Inc.RecruitingNon Small Cell Lung CancerUnited States
-
Rasim GucalpMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Infinity Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedNon Small Cell Lung CancerUnited States
-
Tragara Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Clovis Oncology, Inc.TerminatedLung Cancer | Solid Tumor | Non-small-cell Lung CancerUnited States, United Kingdom
-
CelgeneCompletedSquamous Cell Carcinoma, Non-Small-Cell LungUnited States, Spain, Germany, Italy, United Kingdom
-
The Methodist Hospital Research InstituteGenentech, Inc.Recruiting
-
Abramson Cancer Center at Penn MedicineRecruitingNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedNon-small-cell Lung CancerUnited States
-
Case Comprehensive Cancer CenterTerminatedAdvanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)United States